Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Zosano Pharma Corp (ZSAN)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | | | | | 100.0% | 100.0% |
| Cost of goods sold | 101.4% | 76.3% | | | | | 0.0% | 3.5% |
| Gross profit | -1.4% | 23.7% | | | | | 100.0% | 96.5% |
| Research and development | 2671.8% | 9652.7% | | | | | 6506.7% | 382.8% |
| General and administrative | 1343.6% | 4995.1% | | | | | 2017.6% | 154.5% |
| Depreciation | 223.1% | 636.6% | | | | | 783.4% | 106.3% |
| EBIT | -4016.8% | -14624.1% | | | | | -8424.3% | -440.8% |
| Pre-tax income | -3812.1% | -14896.9% | | | | | -9082.1% | -497.8% |
| Income taxes | 0.0% | 0.0% | | | | | 0.0% | 0.0% |
| Net income | -3812.1% | -14896.9% | | | | | -9082.1% | -497.8% |
|